World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02244996
Date of registration: 17/09/2014
Prospective Registration: Yes
Primary sponsor: The Hong Kong Polytechnic University
Public title: Cone Rescue in Retinitis Pigmentosa by the Treatment of Lycium Barbarum
Scientific title: Cone Rescue in Retinitis Pigmentosa by the Treatment of Lycium Barbarum
Date of first enrolment: November 2014
Target sample size: 50
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02244996
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).  
Phase:  N/A
Countries of recruitment
Hong Kong
Contacts
Name:     Henry HL Chan, PhD
Address: 
Telephone:
Email:
Affiliation:  The Hong Kong Polytechnic University
Key inclusion & exclusion criteria

Inclusion Criteria:

Ocular conditions:

- Retinitis pigmentosa;

- best corrected VA LogMAR 0.20 or better;

- Humphrey Visual Field Analysis (HVFA) 30-2 total mean defect > or = 250 Decibel;

- Intra-ocular pressure (IOP) <21 mmHg;

- van Herrick ratio < or = 0.5;

- no other ocular diseases

Dietary conditions:

- Fruit and vegetable intake <10 servings/day;

- spinach or kale intake < or = serving/day;

- dietary lutein intake < or = 5.4mg/day;

- no intake of cod liver oil or omega-3 capsules;

- dietary Lycium barbarum intake < or =10 fruits/week;

- supplement intake < or = 5000 IU/day of Vit. A and < or = 30 IU/day of Vit. E;

- alcoholic consumption < or = 3 beverages/day

Exclusion Criteria:

- BMI > 40;

- intake of any anticoagulants (especially Warfarin),

- pregnant or planning to be pregnant;

- smoking;

- other clinically significant systemic diseases, eg. diabetes, liver disease and heart
disease



Age minimum: 18 Years
Age maximum: 70 Years
Gender: All
Health Condition(s) or Problem(s) studied
Retinitis Pigmentosa
Intervention(s)
Dietary Supplement: Lycium Barbarum
Dietary Supplement: Placebo
Primary Outcome(s)
ETDRS Visual Acuity (High Contrast) [Time Frame: 12 months]
Secondary Outcome(s)
Implicit Times of Flash Electroretinogram [Time Frame: 12 months]
Amplitudes of Flash Electroretinogram [Time Frame: 12 months]
Visual Field Sensitivity [Time Frame: 12 months]
Secondary ID(s)
01121876
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
The University of Hong Kong
Ethics review
Results
Results available: Yes
Date Posted: 28/01/2019
Date Completed:
URL: https://clinicaltrials.gov/ct2/show/results/NCT02244996
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history